Cancer stem cell as therapeutic target for melanoma treatment

Area of Science:

• Oncology
• Dermatology
• Cancer Stem Cell Research

Background:

• Human malignant melanoma is an aggressive skin cancer known for heterogeneity and resistance to therapies.
• Treatment failure in advanced melanoma is linked to genetically diverse tumor subpopulations, including cancer stem-like cells (CSCs).
• Melanoma stem cells (MSCs) are implicated in intratumoral heterogeneity, disease progression, and drug resistance.

Purpose of the Study:

• To review the scientific evidence supporting the cancer stem cell (CSC) hypothesis in melanoma.
• To evaluate the validity of MSC-dependent pathways as therapeutic targets.
• To identify key molecules within MSCs for potential melanoma treatment strategies.

Main Methods:

• Review of current scientific literature on melanoma heterogeneity and CSCs.
• Analysis of evidence supporting the role of MSCs in melanoma progression and drug resistance.
• Identification of MSC-specific molecular features and pathways.

Main Results:

• CSCs, specifically MSCs, contribute significantly to melanoma's heterogeneity, progression, and therapeutic resistance.
• MSCs possess distinct molecular signatures and activate tumor growth pathways.
• The molecular characteristics of MSCs are linked to melanoma progression, resistance, and recurrence.

Conclusions:

• The CSC hypothesis is supported by evidence in human malignant melanoma.
• MSCs and their associated pathways represent potential therapeutic targets for melanoma.
• Targeting MSC-dependent pathways may offer a novel strategy to overcome treatment failure in advanced melanoma.